Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 20, 4 Issues, 2020
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Open Access Articles

Efficacy of Cangrelor as Bridging Therapy Post PCI

, 2020; 20(3): 227 - 231

Abdul A. Khan, Ghulam Murtaza*, Muhammad Khalid, Mathew Finniss and Thomas Helton









Prognostic Value of Cardiac Biomarkers Assessment in Combination with Myocardial 2D Strain Echocardiography for Early Detection of Anthracycline-Related Cardiac Toxicity

, 2020; 20(1): 74 - 83

Mohammad P. Mahjoob, Seyed A. Sheikholeslami, Morvarid Dadras, Hamdollah Mansouri, Mahshid Haghi, Mohammadreza Naderian, Leila Sadeghi, Mohammadreza Tabary* and Isa Khaheshi*





Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized Trials

, 2020; 20(1): 3 - 15

Sukhdeep Bhogal, Debabrata Mukherjee, Jayant Bagai, Huu T. Truong, Hemang B. Panchal, Ghulam Murtaza, Mustafa Zaman, Rajesh Sachdeva and Timir K. Paul*












Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
(Canada)
Biography
View Full Editorial Board

COPE Compliant

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.46

New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog